ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $258,228 | -16.0% | 12,391 | -3.4% | 0.01% | -15.4% |
| Q2 2023 | $307,255 | +27.3% | 12,829 | 0.0% | 0.01% | +30.0% |
| Q1 2023 | $241,442 | +18.2% | 12,829 | 0.0% | 0.01% | +11.1% |
| Q4 2022 | $204,238 | -4.1% | 12,829 | -1.3% | 0.01% | -18.2% |
| Q3 2022 | $213,000 | +16.4% | 13,000 | 0.0% | 0.01% | +22.2% |
| Q2 2022 | $183,000 | -41.9% | 13,000 | 0.0% | 0.01% | -30.8% |
| Q1 2022 | $315,000 | – | 13,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
| SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
| HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
| Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
| GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
| EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
| Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
| Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |